Suppr超能文献

在印度的一个大样本中,格子状角膜营养不良患者行角膜移植手术的结果。

Outcomes of keratoplasty in lattice corneal dystrophy in a large cohort of Indian eyes.

机构信息

Ophthalmic Biophysics, L V Prasad Eye Institute, Hyderabad, India.

Tej Kohli Cornea Institute, L V Prasad Eye Institute, Hyderabad, India.

出版信息

Indian J Ophthalmol. 2018 May;66(5):666-672. doi: 10.4103/ijo.IJO_1150_17.

Abstract

PURPOSE

The purpose of this study is to evaluate the outcomes of keratoplasty for lattice corneal dystrophy (LCD) performed at a tertiary eye care center.

METHODS

A retrospective review of medical records of those patients who were clinically diagnosed to have LCD (72 eyes of 57 patients) and underwent either penetrating keratoplasty (PK, 58 eyes of 46 patients) or deep anterior lamellar keratoplasty (DALK, 14 eyes of 13 patients) between the years 1987 and 2014 was performed. The main outcome measures included demographics, clinical features, and outcomes of keratoplasty.

RESULTS

The median follow-up after keratoplasty was 3.1 years (interquartile range [IQR], 9 months to 9 years). The median best-corrected visual acuity (BCVA) was 0.18 (IQR, 0.10-0.48) (Snellen equivalent 20/30 [IQR, 20/25-20/60]) at 4 years postoperatively and 0.65 (IQR, 0.18-0.95) (Snellen equivalent 20/89 [IQR, 20/30-20/178]) at 10 years following surgery. DALK eyes had a significantly better BCVA than PK eyes at 2 years following keratoplasty. The median overall survival of grafts was 15.8 years. Late complications included recurrence of LCD (14 eyes), graft infiltrate (23 eyes), graft rejection (15 eyes), graft failure (16 eyes), and glaucoma (14 eyes).

CONCLUSION

The outcomes of graft are similar following PK and deep anterior lamellar keratoplasty; however, the latter appears to provide slightly better visual outcome. Recurrence of dystrophy in the graft and graft infiltrates limit the overall graft survival in both the groups.

摘要

目的

本研究旨在评估在一家三级眼科中心行角膜移植术治疗格子状角膜营养不良(LCD)的结局。

方法

对 1987 年至 2014 年间在我院临床诊断为 LCD 并接受穿透性角膜移植术(PK,46 例患者 58 眼)或深板层角膜移植术(DALK,13 例患者 14 眼)的患者的病历进行回顾性分析。主要观察指标包括人口统计学资料、临床特征和角膜移植术结局。

结果

角膜移植术后的中位随访时间为 3.1 年(四分位距 [IQR],9 个月至 9 年)。术后 4 年时的中位最佳矫正视力(BCVA)为 0.18(IQR,0.10-0.48)(Snellen 等价物 20/30 [IQR,20/25-20/60]),术后 10 年时为 0.65(IQR,0.18-0.95)(Snellen 等价物 20/89 [IQR,20/30-20/178])。DALK 术后 2 年时的 BCVA 明显优于 PK 眼。移植物总存活率的中位数为 15.8 年。晚期并发症包括 LCD 复发(14 眼)、移植物浸润(23 眼)、移植物排斥(15 眼)、移植物失败(16 眼)和青光眼(14 眼)。

结论

PK 和深板层角膜移植术后的移植物结局相似,但后者似乎提供了稍好的视力结果。在两组中,移植物中营养不良的复发和移植物浸润限制了移植物的总体存活率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e21/5939160/df64ffa46075/IJO-66-666-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验